Roland du Bois

2.2k total citations
23 papers, 1.3k citations indexed

About

Roland du Bois is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pathology and Forensic Medicine. According to data from OpenAlex, Roland du Bois has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Roland du Bois's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Roland du Bois is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (17 papers), Sarcoidosis and Beryllium Toxicity Research (7 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers). Roland du Bois collaborates with scholars based in United Kingdom, United States and Germany. Roland du Bois's co-authors include Aryeh Fischer, Ulrich Costabel, Mani S. Kavuru, James F. Donohue, Carlo Albera, Susan Flavin, Gerald S. Davis, Robert P. Baughman, Marjolein Drent and Joachim Müller‐Quernheim and has published in prestigious journals such as The Lancet, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Roland du Bois

23 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roland du Bois United Kingdom 13 1.0k 736 269 214 141 23 1.3k
O P Sharma India 10 920 0.9× 1.0k 1.4× 208 0.8× 52 0.2× 137 1.0× 23 1.4k
Julie Dawson United Kingdom 14 1.0k 1.0× 591 0.8× 300 1.1× 277 1.3× 500 3.5× 31 1.3k
Nabeel Hamzeh United States 20 864 0.8× 872 1.2× 164 0.6× 38 0.2× 72 0.5× 42 1.3k
Juan Mañá Spain 18 711 0.7× 941 1.3× 322 1.2× 34 0.2× 124 0.9× 34 1.1k
Charles Turton United Kingdom 13 645 0.6× 260 0.4× 125 0.5× 114 0.5× 87 0.6× 31 936
Louis DePalo United States 7 1.2k 1.1× 1.2k 1.6× 272 1.0× 22 0.1× 114 0.8× 11 1.5k
P. Latsi Greece 13 1.2k 1.1× 437 0.6× 170 0.6× 149 0.7× 85 0.6× 23 1.3k
John H. Scott United States 6 317 0.3× 547 0.7× 116 0.4× 25 0.1× 81 0.6× 6 763
Nigel Cox United Kingdom 12 249 0.2× 175 0.2× 107 0.4× 92 0.4× 503 3.6× 15 807
Kazumasa Yasuda Japan 13 549 0.5× 176 0.2× 512 1.9× 121 0.6× 231 1.6× 38 940

Countries citing papers authored by Roland du Bois

Since Specialization
Citations

This map shows the geographic impact of Roland du Bois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roland du Bois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roland du Bois more than expected).

Fields of papers citing papers by Roland du Bois

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roland du Bois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roland du Bois. The network helps show where Roland du Bois may publish in the future.

Co-authorship network of co-authors of Roland du Bois

This figure shows the co-authorship network connecting the top 25 collaborators of Roland du Bois. A scholar is included among the top collaborators of Roland du Bois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roland du Bois. Roland du Bois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nathan, Steven D., Carlo Albera, Williamson Z. Bradford, et al.. (2015). Effect of Pirfenidone on IPF-Related Mortality Outcome Measures in Patients With Idiopathic Pulmonary Fibrosis (IPF): Pooled Data Analysis From the ASCEND and CAPACITY Trials. CHEST Journal. 148(4). 391A–391A. 3 indexed citations
2.
Costabel, Ulrich, Carlo Albera, Elizabeth Fagan, et al.. (2014). Long-term safety of pirfenidone in RECAP, an open-label extension study in patients with idiopathic pulmonary fibrosis, interim results. European Respiratory Journal. 44(Suppl 58). 1903–1903. 2 indexed citations
3.
Fischer, Aryeh & Roland du Bois. (2012). Interstitial lung disease in connective tissue disorders. The Lancet. 380(9842). 689–698. 276 indexed citations
4.
Nathan, Steven D., Carlo Albera, Roland du Bois, et al.. (2012). 6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID). 40. 3656. 1 indexed citations
5.
Hilberg, Ole, Ulf Simonsen, Roland du Bois, & Elisabeth Bendstrup. (2012). Pirfenidone: significant treatment effects in idiopathic pulmonary fibrosis. The Clinical Respiratory Journal. 6(3). 131–143. 42 indexed citations
6.
Costabel, Ulrich, Carlo Albera, Alan H. Cohen, et al.. (2011). The long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis (IPF): Interim data from the RECAP extension study. European Respiratory Journal. 38(Suppl 55). 174–174. 16 indexed citations
7.
Jegal, Yangjin, Tae Sun Shim, Chae‐Man Lim, et al.. (2011). Hypoxemia and Arrhythmia during Daily Activities and Six-minute Walk Test in Fibrotic Interstitial Lung Diseases. Journal of Korean Medical Science. 26(3). 372–372. 9 indexed citations
8.
Swigris, Jeffrey J., Xuezhi Zhou, F. S. Wamboldt, et al.. (2009). Exercise peripheral oxygen saturation (Spo2) accurately reflects arterial oxygen saturation (Sao2) and predicts mortality in systemic sclerosis. Thorax. 64(7). 626–630. 38 indexed citations
9.
Swigris, Jeffrey J., Frederick S. Wamboldt, David Sprunger, et al.. (2009). Heart Rate Recovery After 6-Min Walk Test Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis. CHEST Journal. 136(3). 841–848. 77 indexed citations
10.
Spagnolo, Paolo, Luca Richeldi, & Roland du Bois. (2008). Environmental Triggers and Susceptibility Factors in Idiopathic Granulomatous Diseases. Seminars in Respiratory and Critical Care Medicine. 29(6). 610–619. 12 indexed citations
11.
Bois, Roland du & Talmadge E. King. (2007). Challenges in pulmonary fibrosis {middle dot} 5: The NSIP/UIP debate. Thorax. 62(11). 1008–1012. 47 indexed citations
12.
Baughman, Robert P., Marjolein Drent, Mani S. Kavuru, et al.. (2006). Infliximab Therapy in Patients with Chronic Sarcoidosis and Pulmonary Involvement. American Journal of Respiratory and Critical Care Medicine. 174(7). 795–802. 473 indexed citations
13.
Bois, Roland du. (2006). Genetic Factors in Pulmonary Fibrotic Disorders. Seminars in Respiratory and Critical Care Medicine. 27(6). 581–588. 8 indexed citations
14.
Maier, Lisa A., Hiroe Sato, Penny Lympany, et al.. (2003). Influence of MHC CLASS II in Susceptibility to Beryllium Sensitization and Chronic Beryllium Disease. The Journal of Immunology. 171(12). 6910–6918. 93 indexed citations
15.
Petřek, Martin, Jir̆ı́ Drábek, Vı́tězslav Kolek, et al.. (2000). CC Chemokine Receptor Gene Polymorphisms in Czech Patients with Pulmonary Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 162(3). 1000–1003. 88 indexed citations
16.
Foley, Patrick, et al.. (1997). HLA-DPB1 and TAP1 Polymorphisms in Sarcoidosis. CHEST Journal. 111(6). 73S–73S. 8 indexed citations
17.
Bush, Andrew & Roland du Bois. (1996). Congenital and pediatric interstitial disease. Current Opinion in Pulmonary Medicine. 2(5). 347–356. 7 indexed citations
18.
Costabel, Ulrich, Roland du Bois, Anders Eklúnd, et al.. (1994). Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. European Respiratory Journal. 7(3). 624–627. 61 indexed citations
19.
Hansell, David M., et al.. (1993). Interstitial Lung Disease in the Collagen Vascular Diseases. Seminars in Respiratory and Critical Care Medicine. 14(5). 333–343. 8 indexed citations
20.
Gregor, A., et al.. (1979). RADIOGRAPHIC PROGRESSION OF ASBESTOSIS: PRELIMINARY REPORT. Annals of the New York Academy of Sciences. 330(1). 147–156. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O P Sharma Breakdown of academic impact, for papers by Julie Dawson Breakdown of academic impact, for papers by Nabeel Hamzeh Breakdown of academic impact, for papers by Juan Mañá Breakdown of academic impact, for papers by Charles Turton Breakdown of academic impact, for papers by Louis DePalo Breakdown of academic impact, for papers by P. Latsi Breakdown of academic impact, for papers by John H. Scott Breakdown of academic impact, for papers by Nigel Cox Breakdown of academic impact, for papers by Kazumasa Yasuda
Rankless by CCL
2026